996 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
4 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
5 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
8 Available An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Lung Cancer;   Advanced Malignancies;   Carcinoma
Intervention: Drug: Brigatinib
9 Recruiting Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Apatinib;   Drug: Docetaxel
10 Not yet recruiting A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
Conditions: Non Small Cell Lung Cancer;   Breast Cancer
Interventions: Drug: Abemaciclib;   Drug: Pembrolizumab
11 Recruiting Liquid Biopsy for Detection of Driver Mutation in NSCLC
Condition: Non Small Cell Lung Cancer
Intervention: Genetic: detection of driver mutation
12 Not yet recruiting PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
13 Not yet recruiting KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)
Condition: Non-Small Cell Lung Cancer
Intervention:
14 Not yet recruiting A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)
Condition: Non-small Cell Lung Cancer
Interventions: Biological: Pembrolizumab;   Drug: Paclitaxel;   Drug: Nab-paclitaxel;   Drug: Carboplatin;   Drug: Saline placebo for pembrolizumab
15 Not yet recruiting Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma
Condition: Carcinoma, Non-small Cell Lung
Interventions: Drug: Docetaxel;   Drug: Erlotinib
16 Not yet recruiting FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
Conditions: Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Radiation: Radiation Therapy;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Albumin Aggregated;   Drug: Technetium Tc-99m DTPA
17 Recruiting Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer
Condition: Extensive-stage Small Cell Lung Cancer
Interventions: Drug: Temozolomide;   Drug: first-line chemotherapy;   Radiation: Prophylactic cranial irradiation;   Radiation: thoracic radiotherapy
18 Not yet recruiting Study CB-839 in Combination With Nivolumab in Patients With ccRCC and Other Solid Tumors
Conditions: Clear Cell Renal Cell Carcinoma;   Melanoma;   Non-small Cell Lung Cancer
Interventions: Drug: CB-839;   Drug: Nivolumab
19 Not yet recruiting Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC
Condition: Non Small Cell Lung Cancer
Intervention: Drug: AZD9291
20 Not yet recruiting Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer
Conditions: Epidermal Growth Factor Receptor;   Non-Small Cell Lung Cancer
Intervention: Drug: Erlotinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years